EMOTIV Competitors

UC San Francisco is driven by the idea that when the best research, the best education and the best patient care converge, great breakthroughs are achieved. We pursue this integrated excellence with singular focus, fueled by collaboration among our top-ranked professional and graduate schools, medical center, research programs and support teams.

At BrainStorm, we help organizations turn their AI investment into workforce impact. We built our approach around the reality of the adoption gap: AI and software tools get deployed, access is granted, but behavior stays the same. We believe access isn't adoption. Work only changes when people change what they do every day, in real workflows, in the moments where decisions actually happen. That's why we don't treat adoption as a single training event. We're built for sustained, day-to-day change that doesn't come from course completions or one-time trainings. We provide a system designed to orchestrate adoption so new behaviors become the standard way work gets done. We approach change through our ADOPT™ Framework, five deliberate stages from first contact to durable behavior: AWARENESS (why change is needed), DESIRE (motivation to explore), ORIENTATION (how it works in context), PARTICIPATION (starting the new behavior), and TRANSFORMATION (making it stick). Current market options like LMSs, DAPs, upskilling providers, and content libraries manage content and track completions. BrainStorm does all that and more: it drives behavior change after the course ends, connects rollouts to adoption and business outcomes, and orchestrates when and how users engage across channels and over time. Our platform provides customizable multi-channel campaign Flows across email, Teams, and portal; behavior-driven personalization based on role, readiness, and observed usage; adoption analytics connecting learning activity to tool usage and business outcomes; and low-overhead infrastructure that scales without adding headcount. We support AI Readiness, Security Awareness, Enterprise Software Adoption, Customer Success, and more. Across outcomes, the principle is the same: real adoption starts with changing behavior, not merely providing access. We hold ourselves to measurable results because behavior change is visible, not assumed.

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic. With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients. Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.